Last quarter (Q4 2023), Revolution Medicines's total revenue was $742.00K, a decrease of -95.16% from the same quarter last year. In Q4, Revolution Medicines's net income was $-161.54M. See Revolution Medicines’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 11.58M	$ 11.58M	$ 35.38M	$ 29.39M	$ 42.98M	$ 50.04M
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 11.58M	$ 11.58M	$ 35.38M	$ 29.39M	-	-
Operating Expense	$ 498.76M	$ 498.76M	$ -293.66M	$ 217.40M	$ 153.68M	$ 104.16M
Operating Income	$ -487.19M	$ -487.19M	$ -258.28M	$ -188.01M	$ -110.70M	$ -54.12M
Net Non Operating Interest Income Expense	$ 47.48M	$ 47.48M	$ 9.15M	$ 917.00K	$ 2.17M	$ 2.08M
Other Income Expense	$ 188.00K	$ 188.00K	-	-	-	-
Pretax Income	$ -439.89M	$ -439.89M	$ -249.13M	$ -187.09M	$ -108.53M	$ -52.04M
Tax Provision	$ -3.52M	$ -3.52M	$ -420.00K	-	$ -371.00K	$ -4.37M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ -436.37M	$ -436.37M	$ -248.71M	$ -187.09M	$ -110.38M	$ -61.90M
Basic EPS	$ -3.77	$ -3.86	$ -3.08	$ -2.57	$ -2.01	$ -1.17
Diluted EPS	$ -3.77	$ -3.86	$ -3.08	$ -2.57	$ -2.01	$ -1.17
Basic Average Shares	$ 452.60M	$ 113.15M	$ 80.63M	$ 72.81M	$ 54.87M	$ 52.90M
Diluted Average Shares	$ 452.60M	$ 113.15M	$ 80.63M	$ 72.81M	$ 54.87M	$ 52.90M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 498.76M	$ 498.76M	$ -293.66M	$ 217.40M	$ 153.68M	$ 104.16M
Net Income From Continuing And Discontinued Operation	$ -436.37M	$ -436.37M	$ -248.71M	$ -187.09M	$ -108.16M	$ -47.66M
Normalized Income	$ -1.42B	$ -1.54B	-	-	$ -108.16M	$ -47.66M
Interest Expense	-	-	-	-	$ 71.00K	$ 106.00K
EBIT	$ -446.95M	$ -439.89M	$ -249.13M	$ -188.01M	$ -108.46M	$ -51.93M
EBITDA	$ -456.40M	$ -452.79M	$ -242.55M	$ -177.66M	$ -101.91M	$ -48.59M

Currency in USD

Revolution Medicines Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing